Pharma Mar S.A. (PHM) — Net Asset Quality Index
Pharma Mar S.A. (PHM) has a Net Asset Quality Index of 63.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €395.08 Million minus total liabilities of €143.25 Million yields net assets of €251.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Pharma Mar S.A. (PHM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pharma Mar S.A. Net Asset Quality Index Over Time (2002–2025)
This chart shows how Pharma Mar S.A.'s Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the index stands at 63.7%, representing net assets of €251.83 Million against total assets of €395.08 Million EUR. See working capital to net assets of Pharma Mar S.A. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Pharma Mar S.A. (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Pharma Mar S.A. from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see PHM market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 63.7% | €251.83 Million | €395.08 Million | €143.25 Million | ▲ +4.2 pp |
| 2024 | 59.6% | €208.36 Million | €349.64 Million | €141.28 Million | ▲ +2.8 pp |
| 2023 | 56.8% | €193.44 Million | €340.52 Million | €147.08 Million | ▲ +0.1 pp |
| 2022 | 56.7% | €222.96 Million | €393.26 Million | €170.30 Million | ▲ +8.4 pp |
| 2021 | 48.3% | €177.92 Million | €368.39 Million | €190.47 Million | ▲ +17.2 pp |
| 2020 | 31.1% | €102.72 Million | €330.26 Million | €227.54 Million | ▲ +25.1 pp |
| 2019 | 6.0% | €7.46 Million | €124.70 Million | €117.25 Million | ▼ -5.1 pp |
| 2018 | 11.1% | €17.47 Million | €157.68 Million | €140.20 Million | ▼ -1.2 pp |
| 2017 | 12.2% | €22.98 Million | €187.72 Million | €164.74 Million | ▼ -9.7 pp |
| 2016 | 21.9% | €48.49 Million | €221.14 Million | €172.64 Million | ▼ -12.5 pp |
| 2015 | 34.5% | €73.04 Million | €211.94 Million | €138.90 Million | ▲ +4.6 pp |
| 2014 | 29.8% | €60.07 Million | €201.39 Million | €141.32 Million | ▲ +3.7 pp |
| 2013 | 26.1% | €49.44 Million | €189.37 Million | €139.94 Million | ▲ +6.7 pp |
| 2012 | 19.4% | €38.73 Million | €199.83 Million | €161.10 Million | ▲ +3.5 pp |
| 2011 | 15.8% | €34.50 Million | €217.82 Million | €183.31 Million | ▲ +0.7 pp |
| 2010 | 15.1% | €34.86 Million | €230.82 Million | €195.96 Million | ▼ -4.4 pp |
| 2009 | 19.5% | €41.14 Million | €211.31 Million | €170.18 Million | ▼ -4.3 pp |
| 2008 | 23.8% | €49.34 Million | €207.54 Million | €158.20 Million | ▼ -18.8 pp |
| 2007 | 42.5% | €98.81 Million | €232.33 Million | €133.51 Million | ▼ -5.2 pp |
| 2006 | 47.8% | €107.17 Million | €224.41 Million | €117.23 Million | ▼ -43.7 pp |
| 2005 | 91.4% | €360.04 Million | €393.72 Million | €33.68 Million | ▲ +2.1 pp |
| 2004 | 89.3% | €301.23 Million | €337.34 Million | €36.11 Million | ▲ +38.7 pp |
| 2003 | 50.6% | €139.28 Million | €275.47 Million | €136.20 Million | ▼ -10.9 pp |
| 2002 | 61.5% | €166.90 Million | €271.43 Million | €104.53 Million | — |